Danaher CEO To Comment On Financial Performance
News provided by
Share this article
Share this article
WASHINGTON, Jan. 13, 2021 /PRNewswire/ Danaher Corporation (NYSE: DHR) (the Company ) announced that its President and Chief Executive Officer, Rainer M. Blair, will comment today on the Company s fourth quarter 2020 performance in a presentation at the J.P. Morgan Healthcare Conference at 10:50 a.m. ET.
Mr. Blair will communicate that fourth quarter 2020 core revenue growth including Cytiva is expected to be above the Company s previously announced guidance, driven primarily by better performance in its Life Sciences and Diagnostics segments.
For the fourth quarter 2020, estimated revenues increased approximately 38.5% year-over-year, with approximately 15.0% estimated non-GAAP core revenue growth including Cytiva.